Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis.
Abstract
Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated
Citations
Altmetric:
Date
2021-07-16
Type
Article
Subject
Rheumatology, Diseases & disorders of systemic, metabolic or environmental origin
Collections
Citation
Goel R, Morgan M, Chanouzas D, Caplan J, Logan S, Harper L. Rituximab 500 mg 6-monthly infusions is an option in maintenance therapy of ANCA-associated vasculitis. Rheumatol Adv Pract. 2021 Jul 16;5(2):rkab039. doi: 10.1093/rap/rkab039.
Journal / Source Title
Rheumatology Advances in Practice
DOI
10.1093/rap/rkab039
PMID
34632259
Publisher
Oxford University Press